{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:55:55Z","timestamp":1753890955566,"version":"3.41.2"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T00:00:00Z","timestamp":1599782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.576651","type":"journal-article","created":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T11:49:10Z","timestamp":1599824950000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Therapeutic Potential of Targeting Malt1-Dependent TCR Downstream Signaling to Promote the Survival of MHC-Mismatched Allografts"],"prefix":"10.3389","volume":"11","author":[{"given":"Lerisa","family":"Govender","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josip","family":"Mikulic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Christophe","family":"Wyss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Gaide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margot","family":"Thome","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dela","family":"Golshayan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,9,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a015461","article-title":"Effector mechanisms of rejection.","volume":"3","author":"Moreau","year":"2013","journal-title":"Cold Spring Harb Perspect Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1084\/jem.20081937","article-title":"A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy.","volume":"205","author":"Yuan","year":"2008","journal-title":"J Exp Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.trim.2008.08.006","article-title":"Minimization of calcineurin inhibitors to improve long-term outcomes in kidney transplantation.","volume":"20","author":"Golshayan","year":"2008","journal-title":"Transpl Immunol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1093\/intimm\/dxr078","article-title":"Transcriptional control of T-cell development.","volume":"23","author":"Naito","year":"2011","journal-title":"Int Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1586\/1744666X.2014.943191","article-title":"Potential and limitations of regulatory T-cell therapy in solid organ transplantation.","volume":"10","author":"Govender","year":"2014","journal-title":"Expert Rev Clin Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.4161\/cc.10.15.16923","article-title":"From MALT lymphoma to the CBM signalosome: three decades of discovery.","volume":"10","author":"Rosebeck","year":"2011","journal-title":"Cell Cycle."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a003004","article-title":"Antigen receptor signaling to NF-kappaB via CARMA1, BCL10, and MALT1.","volume":"2","author":"Thome","year":"2010","journal-title":"Cold Spring Harb Perspect Biol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1126\/science.1090769","article-title":"Regulation of NF-kappaB-dependent lymphocyte activation and development by paracaspase.","volume":"302","author":"Ruefli-Brasse","year":"2003","journal-title":"Science."},{"key":"B9","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/S1074-7613(03)00293-0","article-title":"Differential requirement for Malt1 in T and B cell antigen receptor signaling.","volume":"19","author":"Ruland","year":"2003","journal-title":"Immunity."},{"key":"B10","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/ni1561","article-title":"T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-kappaB inhibitor A20.","volume":"9","author":"Coornaert","year":"2008","journal-title":"Nat Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"14596","DOI":"10.1073\/pnas.1105020108","article-title":"Malt1-dependent RelB cleavage promotes canonical NF-kappaB activation in lymphocytes and lymphoma cell lines.","volume":"108","author":"Hailfinger","year":"2011","journal-title":"Proc Natl Acad Sci USA."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/ni.3008","article-title":"Cleavage of roquin and regnase-1 by the paracaspase MALT1 releases their cooperatively repressed targets to promote T(H)17 differentiation.","volume":"15","author":"Jeltsch","year":"2014","journal-title":"Nat Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.cell.2013.04.034","article-title":"Malt1-induced cleavage of regnase-1 in CD4(+) helper T cells regulates immune activation.","volume":"153","author":"Uehata","year":"2013","journal-title":"Cell."},{"key":"B14","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1097\/00007890-200104150-00003","article-title":"Differential NF-kappaB and IkappaB gene expression during development of cardiac allograft rejection versus CD154 monoclonal antibody-induced tolerance.","volume":"71","author":"Csizmadia","year":"2001","journal-title":"Transplantation."},{"key":"B15","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1097\/TP.0b013e318166cde1","article-title":"Bioluminescence imaging visualizes activation of nuclear factor-kappaB in mouse cardiac transplantation.","volume":"85","author":"Ma","year":"2008","journal-title":"Transplantation."},{"key":"B16","doi-asserted-by":"publisher","first-page":"5994","DOI":"10.4049\/jimmunol.167.10.5994","article-title":"Inhibition of NF-kappaB-dependent T cell activation abrogates acute allograft rejection.","volume":"167","author":"Finn","year":"2001","journal-title":"J Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1034\/j.1600-6143.2003.00033.x","article-title":"Impaired NF-kappaB activation in T cells permits tolerance to primary heart allografts and to secondary donor skin grafts.","volume":"3","author":"Zhou","year":"2003","journal-title":"Am J Transplant."},{"key":"B18","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1097\/TP.0b013e31824d11d7","article-title":"Role of T-cell-specific nuclear factor kappaB in islet allograft rejection.","volume":"93","author":"Porras","year":"2012","journal-title":"Transplantation."},{"key":"B19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1172\/JCI11914","article-title":"Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer.","volume":"107","author":"Yamamoto","year":"2001","journal-title":"J Clin Invest."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.15252\/embj.201488987","article-title":"Malt1 protease inactivation efficiently dampens immune responses but causes spontaneous autoimmunity.","volume":"33","author":"Jaworski","year":"2014","journal-title":"EMBO J."},{"key":"B21","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.ccr.2012.11.002","article-title":"Pharmacologic inhibition of MALT1 protease by phenothiazines as a therapeutic approach for the treatment of aggressive ABC-DLBCL.","volume":"22","author":"Nagel","year":"2012","journal-title":"Cancer Cell."},{"key":"B22","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1182\/blood-2006-05-025460","article-title":"In vitro-expanded donor alloantigen-specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance.","volume":"109","author":"Golshayan","year":"2007","journal-title":"Blood."},{"key":"B23","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/ni1568","article-title":"The proteolytic activity of the paracaspase MALT1 is key in T cell activation.","volume":"9","author":"Rebeaud","year":"2008","journal-title":"Nat Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1081\/IMM-120016243","article-title":"A simple method for the purification of human peripheral blood antigen presenting cells (dendritic cells, monocytes\/macrophages, and B lymphocytes).","volume":"31","author":"Delles","year":"2002","journal-title":"Immunol Invest."},{"key":"B25","doi-asserted-by":"publisher","first-page":"3723","DOI":"10.4049\/jimmunol.1402254","article-title":"Deficiency of MALT1 paracaspase activity results in unbalanced regulatory and effector T and B cell responses leading to multiorgan inflammation.","volume":"194","author":"Bornancin","year":"2015","journal-title":"J Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"4698","DOI":"10.1172\/JCI63528","article-title":"The NF-kappaB regulator MALT1 determines the encephalitogenic potential of Th17 cells.","volume":"122","author":"Brustle","year":"2012","journal-title":"J Clin Invest."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.4049\/jimmunol.1201351","article-title":"Paracaspase MALT1 deficiency protects mice from autoimmune-mediated demyelination.","volume":"190","author":"Mc Guire","year":"2013","journal-title":"J Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"458","DOI":"10.4161\/cc.7.4.5454","article-title":"Interleukin-2 receptor downstream events in regulatory T cells: implications for the choice of immunosuppressive drug therapy.","volume":"7","author":"Zeiser","year":"2008","journal-title":"Cell Cycle."},{"key":"B29","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/nri3156","article-title":"The role of interleukin-2 during homeostasis and activation of the immune system.","volume":"12","author":"Boyman","year":"2012","journal-title":"Nat Rev Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.ccr.2012.11.003","article-title":"MALT1 small molecule inhibitors specifically suppress ABC-DLBCL in vitro and in vivo.","volume":"22","author":"Fontan","year":"2012","journal-title":"Cancer Cell."},{"key":"B31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.trre.2008.08.007","article-title":"Interleukin 17-producing T helper cells in alloimmunity.","volume":"23","author":"Benghiat","year":"2009","journal-title":"Transplant Rev."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1002\/eji.201242889","article-title":"ERK differentially regulates Th17- and Treg-cell development and contributes to the pathogenesis of colitis.","volume":"43","author":"Liu","year":"2013","journal-title":"Eur J Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"422","DOI":"10.4049\/jimmunol.1303237","article-title":"T cell-intrinsic function of the noncanonical NF-kappaB pathway in the regulation of GM-CSF expression and experimental autoimmune encephalomyelitis pathogenesis.","volume":"193","author":"Yu","year":"2014","journal-title":"J Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1172\/JCI63681","article-title":"IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitis.","volume":"123","author":"Huber","year":"2013","journal-title":"J Clin Invest."},{"key":"B35","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1111\/ajt.12067","article-title":"Cyclosporine A drives a Th17- and Th2-mediated posttransplant obliterative airway disease.","volume":"13","author":"Lemaitre","year":"2013","journal-title":"Am J Transplant."},{"key":"B36","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.4049\/jimmunol.0903961","article-title":"Critical role of regulatory T cells in Th17-mediated minor antigen-disparate rejection.","volume":"185","author":"Vokaer","year":"2010","journal-title":"J Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.celrep.2014.10.044","article-title":"Uncoupling malt1 threshold function from paracaspase activity results in destructive autoimmune inflammation.","volume":"9","author":"Gewies","year":"2014","journal-title":"Cell Rep."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.15252\/embj.201490217","article-title":"MALT1 protease: equilibrating immunity versus tolerance.","volume":"33","author":"Bertossi","year":"2014","journal-title":"EMBO J."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0127083","article-title":"MALT1 protease activity is required for innate and adaptive immune responses.","volume":"10","author":"Yu","year":"2015","journal-title":"PLoS One."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01898","article-title":"MALT1 proteolytic activity suppresses autoimmunity in a T cell intrinsic manner.","volume":"10","author":"Demeyer","year":"2019","journal-title":"Front Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1038\/ni1263","article-title":"A function for interleukin 2 in Foxp3-expressing regulatory T cells.","volume":"6","author":"Fontenot","year":"2005","journal-title":"Nat Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1182\/blood-2006-01-0329","article-title":"Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production.","volume":"108","author":"Zeiser","year":"2006","journal-title":"Blood."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1111\/j.1600-6143.2007.01881.x","article-title":"Effects of cyclosporine on transplant tolerance: the role of IL-2.","volume":"7","author":"Kang","year":"2007","journal-title":"Am J Transplant."},{"key":"B44","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/imcb.1018","article-title":"The T-cell fingerprint of MALT1 paracaspase revealed by selective inhibition.","volume":"96","author":"Bardet","year":"2018","journal-title":"Immunol Cell Biol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s41589-018-0222-1","article-title":"An allosteric MALT1 inhibitor is a molecular corrector rescuing function in an immunodeficient patient.","volume":"15","author":"Quancard","year":"2019","journal-title":"Nat Chem Biol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1002\/ijc.32567","article-title":"Biperiden and mepazine effectively inhibit MALT1 activity and tumor growth in pancreatic cancer.","volume":"146","author":"Konczalla","year":"2020","journal-title":"Int J Cancer."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-11-124","article-title":"Pharmacological inhibition of MALT1 protease activity protects mice in a mouse model of multiple sclerosis.","volume":"11","author":"Mc Guire","year":"2014","journal-title":"J Neuroinflammation."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00421","article-title":"IL-2-Mediated in vivo expansion of regulatory T cells combined with CD154-CD40 Co-stimulation blockade but Not CTLA-4 Ig prolongs allograft survival in naive and sensitized mice.","volume":"8","author":"Govender","year":"2017","journal-title":"Front Immunol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1016\/j.bmcl.2019.03.046","article-title":"Peptide-based covalent inhibitors of MALT1 paracaspase.","volume":"29","author":"Hatcher","year":"2019","journal-title":"Bioorg Med Chem Lett."},{"key":"B50","doi-asserted-by":"publisher","first-page":"4397","DOI":"10.1172\/JCI99436","article-title":"Specific covalent inhibition of MALT1 paracaspase suppresses B cell lymphoma growth.","volume":"128","author":"Fontan","year":"2018","journal-title":"J Clin Invest."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00745","article-title":"Pharmacological inhibition of MALT1 protease leads to a progressive IPEX-like pathology.","volume":"11","author":"Martin","year":"2020","journal-title":"Front Immunol."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3390\/molecules23123144","article-title":"Mepazine inhibits RANK-induced osteoclastogenesis independent of its MALT1 inhibitory function.","volume":"23","author":"Meloni","year":"2018","journal-title":"Molecules."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.576651\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T11:49:12Z","timestamp":1599824952000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.576651\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,11]]},"references-count":52,"alternative-id":["10.3389\/fimmu.2020.576651"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.576651","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2020,9,11]]},"article-number":"576651"}}